This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1.XX Ma , Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 2002; 46: 1147–1152.
2.DM Young , An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients. Archives of Surgery 2004; 139: 947–953.
3.LD Saravolatz , DJ Pohlod , LM Arking . Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Annals of Internal Medicine 1982; 97: 325–329.
4.L Miller , Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. New England Journal of Medicine 2005; 352: 1445–1453.
7.TJ Kowalski , EF Berbari , DR Osmon . Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clinic Proceedings 2005; 80: 1201–1208.
8.H Huang , Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagnostic Microbiology and Infectious Diseases 2008; 60: 347–350.
10.MD King , Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Annals of Internal Medicine 2006; 144: 309–317.
12.KE Nelson , CF Masters Williams . Infectious Disease Epidemiology: Theory and Practice, 2nd edn. Sudbury, MA: Jones & Bartlett Publishers, 2007.
13.H Huang , Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. Journal of Clinical Microbiology 2006; 44: 2423–2427.
15.E Wood , Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal 2004; 1(1): 9.
16.A Costa , Rapid detection of mecA and nuc genes in staphylococci by real-time multiplex polymerase chain reaction. Diagnostic Microbiology and Infectious Disease 2005; 51: 13–17.
17.G Lina , Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128–1132.
20.PD Brown , JR Ebright . Skin and soft tissue infections in injection drug users. Current Infectious Disease Reports 2002; 4: 415–419.
21.DA Talan , PH Summamen , SM Finegold . Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse. Clinical Infectious Diseases 2000; 31: 464–471.
22.GJ Moran , Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666–674.
23.JR Ebright , B Pieper . Skin and soft tissue infections in injection drug users. Infectious Disease Clinics of North America 2002; 16: 697–712.
24.PM Rajendran , Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community acquired methicillin-resistant Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapy 2007; 51: 4044–4048.
25.E Lloyd-Smith , Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduction Journal 2005; 2: 24.
27.L Topp , Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs. Australia and New Zealand Journal of Public Health 2008; 32: 34–37.
28.V Hope , Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infectious Diseases 2008; 8: 120.